Episode 92 Breaking Research: Pharma & Non-Pharma 2023

Join us in this episode as co-hosts Tiffany and Deb share a recap of the 2023 ACR, American College of Rheumatology Conference and how these topics specifically affect AiArthritis diseases. Tiffany and Deb also share an insight into our program, “Go With Us!” to Conferences. The Go With Us program allows patients to attend these conferences in real time and get updates on different important or emerging topics for AiArthritis diseases.

 

In this episode, the co-hosts discuss some main conference topics, both pharma and non-pharma, such as how precision medicine can greatly benefit patients by matching correct treatment plans, how existing treatments are being retested for subgroups and how lifestyle can impact your treatment. Learn common questions doctors receive from patients about their day to day life such as exercise, stress and diet and their advice on how lifestyle modifications can also help to alleviate symptoms. Don’t miss this patient recap of the 2023 ACR conference! 

 

Resources & Links:

 

• To join the Go With Us program, click here: https://www.aiarthritis.org/conferences
• To learn how to volunteer with AiArthritis, check out our program here: https://www.aiarthritis.org/volunteer
• Come be apart of the AiArthritis Research Database here: https://www.aiarthritis.org/database
• To learn more about JIA project, click here: www.aiarthritis.org/JIAcommunication
• Nutrition Resource for Patients : www.tiny.ucsf.edu/rheumnutrition

Episode Highlights: 

• How lifestyle modifications such as exercise, stress and diet can help alleviate symptoms
• Understanding what parts of your immune system is being triggered by your disease for matching to the best treatments 
• Discussion on how early should early intervention be done for JIA 
• The importance of understanding precision medicine to improve matching the correct treatment plan for your AiArthritis disease.
• AiArthritis Go With Us program where you are able to attend the conferences such as ACR and EULAR in real time to understand current and emerging topics that relate to AiArthritis diseases. 
• New therapy option in the very beginning stages being discussed at ACR that has the potential to suppress and protect from autoimmune arthritis diseases. 
• Why supporting research is so important for the development of AiArthritis treatments

Meet Our Host:

 

• Tiffany is the CEO at AiArthritis (International Foundation for Autoimmune & Autoinflammatory Arthritis) and uses her professional expertise in mind-mapping and problem solving to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues.

 

Connect with Tiffany:

• Facebook: @tiffanyAiArthritis
• Twitter: @TiffWRobertson
• LinkedIn: @TiffanyWestrichRobertson

 

• Deb Constien is a medically retired Registered Dietitian and a Representative for the AiArthritis with Rheumatoid Arthritis. Deb is also on the Advisory Council for WREN- Wisconsin Research Education Network and a Patient Family Advisor- PFA on an International PCORI research study for ACP- Advanced Care Planning.

Connect with Deb:

• Facebook: @deb.majcherconstien 
• Instagram: @debconstien
• Twitter:  @debconstien

 

Donate to Support the Show: https://www.aiarthritis.org/donate 

Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE

AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis. Visit us on the web at www.aiarthritis.org/talkshow. Find us on Twitter, Instagram, TikTok, or Facebook (@IFAiArthritis) or email us (podcast@aiarthritis.org).  Be sure to check out our top-rated show on Feedspot!